FIELD: pharmaceutical industry.
SUBSTANCE: invention is characterized by that system contains underlayer, therapeutical substance storage layer, and agent attaching the system on the person's skin and allowing access of nicotine to skin. System is transparent (opacity factor below 48.6%).
EFFECT: facilitated transcutaneous transport of nicotine.
8 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PERCUTANEOUS THERAPEUTIC SYSTEM NOT CONTAINING FIBRE AND METHOD FOR MAKING THEREOF | 2006 |
|
RU2386435C2 |
| PERCUTANEOUS DELIVERY SYSTEM, USING MICROPOROUS MEMBRANE CONTAINING PORES FILLED WITH SOLVENT | 2018 |
|
RU2789194C2 |
| MEANS FOR TRANSCUTANEOUS INTRODUCTION OF NICOTINE | 2005 |
|
RU2334507C2 |
| COMPOSITION FOR TRANSCUTANEOUS DELIVERY OF CATIONIC ACTIVE SUBSTANCES | 2009 |
|
RU2517241C2 |
| TRANSDERMAL PLASTER FOR FENTANYL INTRODUCTION | 2007 |
|
RU2351318C2 |
| TRANSDERMAL PATCH FOR ADMINISTERING FENTANYL | 2002 |
|
RU2708563C2 |
| PERCUTANEOUS THERAPEUTIC SYSTEM CONTAINING NEUTRALIZED ACRYLATE-BASED ADHESIVE SUBSTANCES GLUING AT PRESSING | 2000 |
|
RU2242971C2 |
| TRANSDERMAL PATCH FOR ADMINISTERING FENTANYL | 2002 |
|
RU2657397C2 |
| TRANSDERMAL PLASTER FOR ADMINISTRATION OF FENTANYL | 2002 |
|
RU2301059C2 |
| TRANSDERMAL DELIVERY OF LAZOPHOXIPHEN | 2001 |
|
RU2328276C2 |
